FindTrial
Sign In

Risk factors and clinical outcomes in Ventilator associated Pneumonia

Risk factors, antimicrobial regimens, and clinical outcomes of Ventilator Associated Pneumonia due to carbapenem resistant bacteria: A prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/113199
Enrollment
115
Registered
2026-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J958- Other intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Shobhitha Krishnan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above 18 years of age with Ventilator Associated Pneumonia caused by Carbapenem Resistant Bacteria

Exclusion criteria

Exclusion criteria: Patients below 18 years of age Patients with ventilator associated pneumonia due to Carbapenem sensitive bacteria

Design outcomes

Primary

MeasureTime frame
28 day or in hospital mortality in patients with Carbapenem Resistant Ventilator Associated PneumoniaTimepoint: At 4 weeks—

Secondary

MeasureTime frame
Association between Antimicrobial regimens used & mortality in Carbapenem resistant VAPTimepoint: At baseline, 4 weeks;Prevalence of AKI in patients with Carbapenem Resistant VAPTimepoint: At baseline, 4 weeks;Validity of RISC score in predicting 28 day mortality in patients with Carbapenem Resistant VAPTimepoint: At 4 weeks;Association of weaning pattern with mortality in Carbapenem Resistant VAPTimepoint: At 4 weeks—

Countries

India

Contacts

Public ContactDr Manu Mohan K

Kasturba Medical College, MAHE

manu.mohan@manipal.edu9964896253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026